Literature DB >> 21386707

Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden.

Jonathan N Hofmann1, Anna Törner, Wong-Ho Chow, Weimin Ye, Mark P Purdue, Ann-Sofi Duberg.   

Abstract

Chronic hepatitis C virus (HCV) infection is an established cause of liver cancer, and recent studies have suggested a link with kidney cancer. The aim of this study was to evaluate risk of kidney cancer in relation to HCV infection in a nationwide registry-based study of Swedish residents diagnosed with HCV between 1990 and 2006. A total of 43 000 individuals with chronic HCV infection were included, and the mean follow-up time was 9.3 years. Observed kidney cancer incidence and mortality in the cohort were compared with expected values based on the age-adjusted and sex-adjusted rates in the general population. Risk of hospitalization for other chronic kidney disease was also evaluated using Cox proportional hazards regression. No association between HCV infection and risk of kidney cancer was observed [standardized incidence ratio with 1-year lag=1.2; 95% confidence interval (CI): 0.8-1.7]. Risk of hospitalization for noncancer kidney disease was significantly elevated in the HCV cohort, with significantly stronger associations observed among women than among men [hazard ratio=5.8 (95% CI: 4.2-7.9) and 3.9 (95% CI: 3.2-4.8) for women and men, respectively]. Results of this study do not support the hypothesis that chronic HCV infection confers an increased risk of kidney cancer. However, we did find an association between HCV infection and chronic kidney disease, particularly among women. Given inconsistent findings in the literature, it is premature to consider HCV infection to be a risk factor for kidney cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21386707      PMCID: PMC3104067          DOI: 10.1097/CEJ.0b013e32834572fa

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  19 in total

Review 1.  Hepatitis C and renal disease: an update.

Authors:  Catherine M Meyers; Leonard B Seeff; Catherine O Stehman-Breen; Jay H Hoofnagle
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 2.  Gender differences in chronic kidney disease: underpinnings and therapeutic implications.

Authors:  Juan Jesús Carrero
Journal:  Kidney Blood Press Res       Date:  2010-10-14       Impact factor: 2.687

3.  Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.

Authors:  Luigino Dal Maso; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

4.  Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.

Authors:  Ann-Sofi Duberg; Marie Nordström; Anna Törner; Olle Reichard; Reinhild Strauss; Ragnhild Janzon; Erik Bäck; Karl Ekdahl
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

5.  Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998-2002, assessed by the capture-recapture method.

Authors:  A Jansson; M Arneborn; K Ekdahl
Journal:  Epidemiol Infect       Date:  2005-06       Impact factor: 2.451

6.  Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.

Authors:  Janaki Amin; Gregory J Dore; Dianne L O'Connell; Mark Bartlett; Elizabeth Tracey; John M Kaldor; Matthew G Law
Journal:  J Hepatol       Date:  2006-03-31       Impact factor: 25.083

Review 7.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

8.  Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection.

Authors:  D Sansonno; G Lauletta; M Montrone; G Grandaliano; F P Schena; F Dammacco
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

9.  The burden of hepatitis C in Sweden: a national study of inpatient care.

Authors:  A-S Duberg; H Pettersson; S Aleman; A Blaxhult; L Daviðsdóttir; R Hultcrantz; E Bäck; K Ekdahl; S M Montgomery
Journal:  J Viral Hepat       Date:  2011-02       Impact factor: 3.728

10.  Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.

Authors:  Judith I Tsui; Eric Vittinghoff; Michael G Shlipak; Daniel Bertenthal; John Inadomi; Rudolph A Rodriguez; Ann M O'Hare
Journal:  Arch Intern Med       Date:  2007-06-25
View more
  17 in total

Review 1.  Hepatitis C virus infection and kidney disease: a meta-analysis.

Authors:  Fabrizio Fabrizi; Paul Martin; Vivek Dixit; Piergiorgio Messa
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

2.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 3.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

4.  Chronic hepatitis C infection as a risk factor for renal cell carcinoma.

Authors:  Humberto C Gonzalez; Lois Lamerato; Craig G Rogers; Stuart C Gordon
Journal:  Dig Dis Sci       Date:  2015-01-17       Impact factor: 3.199

Review 5.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

Review 6.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

7.  Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection.

Authors:  Sara Yee Tartof; Jin-Wen Hsu; Rong Wei; Kevin B Rubenstein; Haihong Hu; Jean Marie Arduino; Michael Horberg; Stephen F Derose; Lei Qian; Carla V Rodriguez
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 8.237

8.  Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.

Authors:  J Huang; M Magnusson; A Törner; W Ye; A-S Duberg
Journal:  Br J Cancer       Date:  2013-10-31       Impact factor: 7.640

9.  Identification of genes and pathways involved in kidney renal clear cell carcinoma.

Authors:  William Yang; Kenji Yoshigoe; Xiang Qin; Jun S Liu; Jack Y Yang; Andrzej Niemierko; Youping Deng; Yunlong Liu; A Dunker; Zhongxue Chen; Liangjiang Wang; Dong Xu; Hamid R Arabnia; Weida Tong; Mary Yang
Journal:  BMC Bioinformatics       Date:  2014-12-16       Impact factor: 3.169

10.  Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning.

Authors:  Xiangyu Li; Woonghee Kim; Kajetan Juszczak; Muhammad Arif; Yusuke Sato; Haruki Kume; Seishi Ogawa; Hasan Turkez; Jan Boren; Jens Nielsen; Mathias Uhlen; Cheng Zhang; Adil Mardinoglu
Journal:  iScience       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.